Andrew Perry, Chief Commercial Officer at G1 Therapeutics, Inc. (GTHX), sold 8,151 shares at $4.79 ($39K) on 2024-05-13, disclosed to the SEC on 2024-05-15.
Open-market sale of $39k GTHX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| GTHX | SELL | 2023-07-07 | $870 | — | Filing → |
| GTHX | SELL | 2023-01-05 | $5K | — | Filing → |